XML 33 R10.htm IDEA: XBRL DOCUMENT v3.20.1
Lease liabilities
3 Months Ended
Mar. 31, 2020
Leases [Abstract]  
Lease liabilities

4. Lease liabilities

The Company has a lease agreement for approximately 6,272 square feet of office space in Seattle, Washington, for the Company’s principal executive offices, a laboratory for research and development and related uses. The lease became effective on September 23, 2019, commenced on October 1, 2019 and expires on October 31, 2021, unless terminated earlier. The Company is also responsible for the payment of additional rent to cover the Company’s share of the annual operating and tax expenses and utilities costs for the building.

The Company has a new lease agreement for approximately 33,300 square feet of office space in Seattle, Washington, for the Company’s future principal executive offices, a laboratory for research and development and related uses (the “New Seattle Lease”). The lease commenced on January 15, 2020 and rent obligations are scheduled to commence on December 1, 2020. The lease expires on December 1, 2028, with the option to extend the lease for two five-year terms. The lease provides for a tenant improvement allowance of $8.0 million, which is included in the base rent, and an optional additional tenant improvement allowance with a maximum amount of $1.5 million, which will result, if elected, in additional rent amortized over the term of the lease. The Company will also be responsible for the payment of additional rent to cover the Company’s share of the annual operating and tax expenses and utilities costs for the building. In January 2020, the Company issued an irrevocable letter of credit in the amount of $0.5 million for the security deposit, in accordance with the terms of the lease.

The Company has a lease agreement for approximately 10,946 square feet of office space in Vancouver, Canada, which commenced on November 1, 2016 and expires October 31, 2021, with the option to extend the lease to October 31, 2026. In addition to the basic rent, the Company is obligated to pay for taxes, operating costs, utilities, additional services and other amounts.  

The Company has a finance lease liability for laboratory equipment which expires June 2023. The Company is obligated to make five annual payments for an aggregate purchase price of $0.3 million. All rights and title will transfer to the Company upon receipt of the final payment.  

As of March 31, 2020, and December 31, 2019, the Company’s operating lease right-of-use assets were $10.3 million and $0.8 million, respectively. The Company’s finance lease right-of-use assets were $0.3 million as of March 31, 2020 and December 31, 2019.

The components of the lease expense were as follows:

 

 

 

THREE MONTHS ENDED
MARCH 31,

 

(in thousands)

 

2020

 

 

2019

 

Finance lease cost

 

 

 

 

 

 

 

 

Amortization of right-of-use assets

 

$

12

 

 

$

 

Interest on lease liabilities

 

 

 

 

 

 

Operating lease cost

 

 

528

 

 

 

31

 

Short term lease cost

 

 

28

 

 

 

 

Variable lease cost

 

 

74

 

 

 

48

 

Total net lease cost

 

$

642

 

 

$

79

 

 

 

Supplemental balance sheet information related to leases is as follows:

 

 

 

THREE MONTHS ENDED
MARCH 31,

 

 

 

2020

 

 

2019

 

Weighted average remaining lease term – finance leases

 

3.12 years

 

 

1.42 years

 

Weighted average remaining lease term – operating leases

 

8.11 years

 

 

2.58 years

 

Weighted average discount rate – finance leases

 

 

7.11%

 

 

 

6.94%

 

Weighted average discount rate – operating leases

 

 

12.63%

 

 

 

6.00%

 

 

Supplemental cash flow information related to leases was as follows:

 

 

 

THREE MONTHS ENDED
MARCH 31,

 

(in thousands)

 

2020

 

 

2019

 

Cash paid for amounts included in the measurement of operating lease liabilities

 

$

310

 

 

$

41

 

Cash paid for amounts included in the measurement of finance lease liabilities

 

 

2

 

 

 

2

 

Operating lease liabilities arising from obtaining right-of-use assets

 

9,614

 

 

515

 

 

The calculation of the present value of the operating lease payments for the Vancouver lease and the lease for the future principal offices and laboratory space did not include the options to extend the lease.

At March 31, 2020, the future payments under the Company’s operating and finance lease liabilities were as follows:

 

(in thousands)

 

FINANCE
LEASE

 

 

OPERATING
LEASE

 

December 31, 2020 (remaining nine months)

 

$

62

 

 

$

414

 

December 31, 2021

 

 

60

 

 

 

2,502

 

December 31, 2022

 

 

60

 

 

 

2,086

 

December 31, 2023

 

 

60

 

 

 

2,139

 

December 31, 2024

 

 

 

 

 

2,192

 

Thereafter

 

 

 

 

 

9,124

 

Total undiscounted lease payments

 

 

242

 

 

 

18,457

 

Less: imputed interest

 

 

(37

)

 

 

(7,734

)

Total lease liabilities

 

205

 

 

10,723

 

Less: current portion

 

 

(59

)

 

 

(541

)

Non-current lease liabilities – March 31, 2020

 

$

146

 

 

$

10,182